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Abstract
Matrix-assisted laser desorption ionization time-of-ﬂight (MALDI-TOF) mass spectrometry (MS) is a fast and reliable technology for the
identiﬁcation of microorganisms with proteomics approaches. Here, we compare an intact cell method and a protein extraction method
before application on the MALDI plate for the direct identiﬁcation of microorganisms in both urine and blood culture samples from
clinical microbiology laboratories. The results show that the intact cell method provides excellent results for urine and is a good initial
method for blood cultures. The extraction method complements the intact cell method, improving microorganism identiﬁcation from
blood culture. Thus, we consider that MALDI-TOF MS performed directly on urine and blood culture samples, with the protocols that
we propose, is a suitable technique for microorganism identiﬁcation, as compared with the routine methods used in the clinical microbi-
ology laboratory.
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Introduction
The identiﬁcation of microorganisms in clinical microbiology
laboratories is currently based on Gram staining, culture and
growth characteristics, and biochemical patterns. These pro-
cedures are cumbersome and time-consuming. Molecular
methods have been introduced recently, but they are expen-
sive and time-consuming, and they are not currently suitable
for routine identiﬁcation. Matrix-assisted laser desorption
ionization time-of-ﬂight (MALDI-TOF) mass spectrometry
(MS) is becoming a reliable method for the identiﬁcation of
microorganisms [1,2]. The use of MALDI-TOF MS for micro-
organism identiﬁcation in clinical samples has been rare until
recently, mainly because broad microorganism protein data-
bases have become available only recently, and because of
the high price of mass spectrometers [3–8]. Although univer-
sal sample preparation methods have been proposed [9],
many different protocols are being used. The ‘intact’ cell
technique, in which a single colony from a culture plate is
spread onto the MALDI plate and overlaid with matrix, ini-
tially described in 1996 [2], has been applied for routine
identiﬁcation of bacteria in clinical samples [8,10]. Likewise,
several methods for sample preparation and protein extrac-
tion have been proposed [11–13]. However, these
approaches require culture of the original clinical specimen.
Thus, the identiﬁcation is delayed for at least 18–24 h, until
visible colonies have grown, and can even be delayed for
weeks for microorganisms such as Mycobacterium tuberculosis.
Other clinically relevant bacteria, such as Treponema pallidum,
simply fail to grow on culture media. Recently, several labo-
ratories have described the identiﬁcation of microorganisms
directly from blood cultures (BCs) [14–20] and from urine
[21] with different protein extraction methods (PEMs).
The aim of the present study was to compare the direct
deposition of microorganisms onto the MALDI plate (intact
cell method (ICM)) with the protein extraction and applica-
tion on the MALDI plate for direct identiﬁcation of clinical
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microorganisms in urine and BC samples by MALDI-
TOF MS.
Materials and Methods
Clinical samples
We analysed 238 urine samples and 68 BC samples submitted
to the Microbiology Laboratory from inpatients and
outpatients. Urine samples were collected in Vacutainer tubes
without preservatives (Becton Dickinson, Franklin Lake, NJ,
USA). Samples reported to be positive by the automated
screening urine ﬂow cytometry analyser (UF-1000i; Bio-
Me´rieux, Marcy L’E´toile, France) were cultured on blood agar
and McConkey agar plates. Plates were incubated in an aero-
bic atmosphere at 37C for 18 h. The colonies grown were
identiﬁed by conventional methods. Only samples with colony
counts >105 CFU/mL were considered for the study. MALDI-
TOF MS was always performed within 24 h after sample
collection, samples being kept at 4C until their analysis.
Eight millilitres of blood, obtained aseptically by vein punc-
ture, were inoculated into BC bottles (Becton Dickinson)
and incubated at 37C in a BD Bactec 9000 analyser (Becton
Dickinson) until they were reported as positive or for a
maximum of 10 days. No speciﬁc anaerobic bottles were
used. Samples not reported as positive by the analyser after
10 days of incubation were discarded and reported as nega-
tive without plate culture. For samples reported by the ana-
lyser as presumptively positive, a Gram stain was performed,
and 100 lL of the sample was cultured on blood, chocolate,
McConkey and Sabouraud agar plates and incubated in an
aerobic atmosphere with 10% CO2 at 37C for 18–24 h.
Negative plates were incubated for a further 48 h, and if
they remained negative they were discarded. When bacterial
growth occurred, colonies were identiﬁed by conventional
methods (WIDER MIC/ID Gram positive and WIDER MIC/
ID Gram negative (MicroScan, Sacramento, CA, USA) and
Auxacolor 2 (Bio-Rad, Marnes-la-Coquette, France)).
MALDI-TOF MS
For MS, 4 mL of urine or BC were centrifuged at 2000 g for
30 s to remove blood cells. The supernatant was centrifuged
at 15 500 g for 5 min to collect bacteria. The pellet obtained
was washed once with de-ionized water. A small amount of
sediment was spotted twice onto a target MALDI plate with
a sterilized pipette tip, and left to dry in air at room temper-
ature. This was the ICM (Fig. 1).
In the PEM, an ethanol–formic acid extraction method
was used. The bacterial pellet was resuspended in 300 lL of
water. Then, 900 lL of absolute ethanol was added, the
mixture was centrifuged at 15 500 g for 2 min, and the
supernatant was discarded. Fifty microlitres of formic acid
(70% v/v) was added to the pellet and thoroughly mixed by
pipetting before the addition of 50 lL of acetonitrile to the
mixture. The mixture was centrifuged again at 15 500 g for
2 min. One microlitre of the supernatant was placed onto a
spot of the steel target plate and air-dried at room tempera-
ture (Fig. 1).
Both the microbial ﬁlm and the supernatant of the
extracted proteins were overlaid with 1 lL of matrix solu-
tion (a saturated solution of a-cyano-4-hydroxycinnamic acid
in organic solvent (50% acetonitrile and 2.5% triﬂuoroacetic
acid)) and air-dried.
MALDI-TOF MS was performed on an Autoﬂex III instru-
ment (Bruker Daltonics, Leipzig, Germany) equipped with a
200-Hz smartbeam laser. The spectra were recorded in the
positive linear mode at the maximum laser frequency within
a mass range from 2000 to 20 000 Da. The instrument
parameter settings were as follows: ion source 1 at 20 kV,
ion source 2 at 18.6 kV, lens at 6 kV and an extraction delay
time of 4 ns. For each spectrum, 500 laser shots were col-
lected and analysed (50 laser shots from different positions
of the target spot, ten times). The spectra were calibrated
Blood culture Urine
4 mL
Centrifuge, 2000 g, 30 s
Supernatant Pellet
Centrifuge, 15 500 g, 5 min
Supernatant Pellet
Wash with de-ionized water and centrifuge again
Pellet
Apply to the MALDI plate Resuspend in 300 μL of water
Add 900 μL of absolute ethanol
Centrifuged, 15 500 g, 2 min
Supernatant Pellet
Resuspend in 50 μL of formic acid (70% v/v) 
Add 50 μL acetonitrile 
Centrifuged, 15 500 g, 2 min
Supernatant Pellet
Apply 1 μL to the MALDI plate 
Extraction method
Intact cell method
FIG. 1. Diagram of the general workﬂow in the analysis of urine and
blood culture samples by matrix-assisted laser desorption ionization
(MALDI) time-of-ﬂight mass spectrometry.
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externally with the standard calibration mixture (Escherichia
coli extracts including the additional proteins RNase A and
myoglobin; Bruker Daltonics). Calibration masses were as
follows: RL36, 4364.3 Da; RS22, 5095.8 Da; RL34,
5380.4 Da; RLmeth, 6254.4 Da; RL32, 6315.2 Da; RL29,
7273.5 Da; RS19, 10229.1 Da; RNase A, 13682.2 Da; myo-
globin, 16952.5 Da.
Spectra were analysed automatically with Biotyper 2.0
software (Bruker Daltonics), containing reference libraries of
3290 microbial species. The software performs normaliza-
tion, smoothing, baseline subtraction and peak picking, creat-
ing a list of the most signiﬁcant peaks of the spectrum (m/z
values with a given intensity, with the threshold set to a min-
imum of 1% of the highest peak and a maximum of 100
peaks). To identify bacteria, the peak list generated was
matched against reference libraries, with the integrated pat-
tern-matching algorithm of the software. Once the spectrum
was imported into the Biotyper software, the whole process,
from processing to identiﬁcation, was performed automati-
cally. The results of the pattern-matching process were
expressed as score values, which ranged from 0 to 3.
MALDI-TOF MS identiﬁcations were classiﬁed by modifying
score values proposed by the manufacturer: a score ‡2 indi-
cated species identiﬁcation, a score between 1.7 and 2 indi-
cated genus identiﬁcation, and a score <1.7 indicated no
reliable identiﬁcation.
Results and Discussion
Two hundred and thirty-eight urine samples were processed
directly by both plate culture and biochemical identiﬁcation
and MALDI-TOF MS. The microorganisms identiﬁed by
MALDI-TOF MS are given in Table 1. Twenty urine samples
reported as presumptively positive by the screening device
were negative in culture. All of them were reported as ‘no
reliable identiﬁcation’ by MALDI-TOF MS. For the 218 urine
samples conﬁrmed to be positive by culture, conventional
identiﬁcation and MALDI-TOF MS were coincident at the
species level in 203 cases, and at the genus level in 204
cases. MALDI-TOF MS failed to identify any microorganism
in the 14 remaining samples, probably because the number
of microorganisms in the sample was not high enough. We
have reported that bacterial counts are critical to achieve
reliable results in MALDI-TOF MS of clinical samples. When
urine samples have a high bacterial load (>105 CFU/mL), cor-
relation with conventional identiﬁcation is 91.8% at the spe-
cies level, and 92.7% at the genus level. Nevertheless, the
number of microorganisms required for MALDI-TOF MS
identiﬁcation depends on the species. For example, in the
case of Enterococcus faecalis, the bacterial count has to be
higher than 5 · 105 CFU/mL [21].
We compared the results obtained with the ICM and the
PEM for MALDI-TOF MS with the 20 urine samples negative
in culture and with the 204 samples that gave the same
results with conventional identiﬁcation and MALDI-TOF MS
(Fig. 2). All of the 20 culture-negative samples were reported
as ‘no reliable identiﬁcation’ by both the ICM and the PEM.
Of the remaining 204 positive samples, 192 were coincident
at the species level (94%), and 193 (95%) at the genus level.
Fig. 3 shows that, for urine samples, spectra obtained for
Proteus mirabilis and Klebsiella pneumoniae by both methods
were very similar. We found some differences in only 11
positive samples (5%). Five samples (three E. coli, one P. mira-
bilis and one Raoultella ornithinolytica) were identiﬁed with the
ICM (2%), but not with the PEM. Moreover, six samples
(three E. coli, two Enterococcus faecalis and one Enterobacter
cloacae) were only identiﬁed with the PEM (3%). The reason
why some reliable identiﬁcations were obtained only with
the ICM may be that, in some cases, most of the bacterial
pellet was spread on the MALDI plate, and there might not
have been enough of the remaining pellet for the subsequent
PEM. The reason why some reliable identiﬁcations were
obtained only with the PEM may be that this method
increases cell wall lysis, enabling proteins to be thoroughly
extracted, giving more and stronger signals.
In most samples, the score was >2 with both MALDI-
TOF MS methods (170 of 204 cases with the ICM and 179
of 204 with the PEM). Scores between 1.7 and 2.0 were
TABLE 1. Microorganism identiﬁcation by matrix-assisted
laser desorption ionization time-of-ﬂight mass spectrometry
in urine and blood culture samples
Microorganisms identiﬁed
Urine Blood
No. of isolates No. of isolates
Acinetobacter baumannii – 1
Citrobacter freundii 1 –
Citrobacter koseri 1 –
Enterobacter asburiae 1 –
Enterobacter cloacae 6 –
Enterobacter hormaechei – 1
Enterococcus faecalis 7 5
Escherichia coli 163 4
Klebsiella oxytoca 7 –
Klebsiella pneumoniae 7 3
Morganella morganii 1 1
Proteus mirabilis 4 –
Pseudomonas aeruginosa 1 2
Raoultella sp. 1 –
Serratia marcescens 2 2
Staphylococcus aureus 2 1
Staphylococcus epidermidis – 15
Staphylococcus haemolyticus – 2
Staphylococcus hominis – 10
Staphylococcus sp. – 12
Staphylococcus warneri – 1
Streptococcus pneumoniae – 2
Streptococcus pyogenes – 3
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obtained in 26 of 204 cases with the ICM and in 19 of 204
cases with the PEM. Scores <1.7 were obtained in eight
cases with the ICM and in six cases with the PEM. The aver-
age scores were 2.20 for the ICM and 2.21 for the PEM.
Among the cases coincident at species level, 100 samples
had higher scores with the PEM and 90 samples had higher
scores with the ICM. In two cases, the score was the same
with both methods.
The MALDI-TOF MS identiﬁcations for BCs are shown in
Table 1. When we compared the results obtained with con-
ventional microbiological methods and MALDI-TOF MS, we
found 76% (52/68 cases) coincident at the species level, and
96% (65/68) at the genus level. In 12 of 13 cases, the species
identiﬁed only at the genus level were Staphylococcus species
(two Staphylococcus capitis, eight Staphylococcus epidermis, one
Staphylococcus haemolyticus and one Staphylococcus hominis);
one of 13 cases was Enterobacter. We should keep in mind
that, when MALDI-TOF MS and biochemical identiﬁcation
disagree, 16S rDNA sequencing frequently conﬁrms MALDI-
TOF MS results [19]. On the other hand, in three cases
there was no identiﬁcation by MALDI-TOF MS (4%),
although plate culture and biochemical identiﬁcation pro-
vided reliable identiﬁcation (one Staphylococcus aureus and
two S. hominis). Again, these MALDI-TOF MS identiﬁca-
tion failures are probably attributable to a low number of
microorganisms in the sample. Christner et al. [17] have
recently reported that, for microorganism identiﬁcation in
BCs by MALDI-TOF MS, microorganism concentrations
>106 CFU/mL are needed to obtain suitable proﬁles for MS
identiﬁcation.
Concerning the methods compared, of the 65 samples
identiﬁed by MALDI-TOF MS, 32 (49%) were correctly iden-
tiﬁed with both the ICM and the PEM at the species level,
and 33 (51%) at the genus level. Thirty-two samples (49%)
were correctly identiﬁed with only one method. Thirty sam-
ples (46%) were identiﬁed only with the PEM; the ICM gave
‘no peaks found’ or ‘no reliable identiﬁcation’. These samples
were as follows: two Staphylococcus warneri, eight S. hominis,
three S. haemolyticus, 10 S. epidermidis, one S. aureus, one
S. capitis, two Streptoccus pyogenes, one Streptoccus pneumo-
niae, one Serratia marcescens and one E. faecalis. In two sam-
ples (one S. epidermidis and one S. hominis) (3%), correct
identiﬁcation was obtained only with the ICM, the PEM giving
‘no peaks found’ or ‘no reliable identiﬁcation’ (Fig. 2).
Score values obtained for BC samples were lower than
those for urine samples. Scores >2 were obtained in 18/65
BCs with the ICM, and in 35/65 with the PEM; scores were
between 1.7 and 2.0 in 13 cases with the ICM, and in 18
cases with the PEM. Scores <1.7 were obtained in 34 cases
with the ICM, and in 12 cases with the PEM. In most
instances, even MALDI-TOF MS identiﬁcations with score
values below 1.7 were coincident with conventional bio-
chemical identiﬁcation. The average scores were 1.75 for the
ICM and 2.02 for the PEM. The PEM fundamentally and sig-
niﬁcantly improved the score in the genus Staphylococcus.
Routine identiﬁcation procedures require at least 24–48 h.
Recently, MALDI-TOF MS has been introduced in clinical lab-
oratories, where rapid and reliable identiﬁcation is of the
utmost importance [3–8,14,15]. MALDI-TOF MS signiﬁcantly
reduces the time required for reliable identiﬁcation, which
can be obtained in minutes. Several studies have addressed
the application of MALDI-TOF MS to the identiﬁcation of
microorganisms in BCs, and in all cases sample preparation
included protein extraction procedures before spotting onto
the target plate for MALDI-TOF MS measurements [14–20].
Nevertheless, there are no standardized protocols for sam-
ple preparation. La Scola and Raoult [14] used two different
protocols, with a series of three centrifugation steps each,
whereas Stevenson et al. [15] employed a protocol with a
series of seven centrifugation steps. Ferroni et al. [18] used
an extraction method with detergent and triﬂuoroacetic acid
for extracting proteins. Christner et al. [17] processed bacte-
rial cultures with formic acid extraction for MS. In all cases,
the protocols are lengthy and require more processing steps
and more sample manipulation than the method that we pro-
pose here. In our method, sample processing requires
only urine and BC centrifugation, spreading of the sediment
onto the MALDI plate, recording of the mass spectrum, and
Urine
Blood
culture
193 (95%)
5 (2%)
6 (3%)
11 (5%)
Match (genus) No match Direct method Extraction method
33 (51%)
2 (3%)
30 (46%)
32 (49%)
FIG. 2. Comparison of the intact cell method and the extraction
method in urine and blood culture samples analysed by matrix-
assisted laser desorption ionization time-of-ﬂight mass spectrometry.
The samples compared are those with coincidence at the genus level
with plate culture and biochemical identiﬁcation.
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identiﬁcation with the dedicated software for the ICM. The
whole process takes about 10 min for one sample and about
20 min for 20 samples. The PEM imposes two more centrifu-
gation steps, and the whole process takes about 20 min for
one sample and 60 min for 20 samples.
Our results show that, with 4 mL of urine, the ICM gives
almost the same results as the PEM, and is effective in 97% of
cases. Therefore, it might not be necessary to extract the
proteins before spreading the sample onto the MALDI plate,
with the concomitant saving of time and the advantage of less
sample manipulation. Regarding BCs, the PEM provides better
results than the ICM, but identiﬁcation with the ICM is reli-
able in half of the samples (49% at the species level and 51%
at the genus level). We propose that the ICM should initially
be applied to all samples and, if reliable identiﬁcation is not
achieved, the PEM should be applied to increase the number
Proteus mirabilis
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FIG. 3. Mass spectra (size 2.000–11.000 Da)
of Proteus mirabilis and Klebsiella pneumoniae
from urine samples obtained with the intact
cell method (a) and with the protein extrac-
tion method (b). a.u., arbitrary units.
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of identiﬁcations. The protocol that we propose is easier and
faster than that previously proposed for BCs [14–20].
In conclusion, MALDI-TOF MS is an outstanding method
for the identiﬁcation of microorganisms in clinical samples.
The method is not time-consuming, and it is possible to
report analytical results in minutes. The ICM affords excel-
lent results with urine samples. Results for BC samples are
not as signiﬁcant as those for urine samples, but identiﬁca-
tion is reliable when it is obtained, and would reduce the
number of samples to be processed with the PEM by 50%. In
both cases, MALDI-TOF MS identiﬁcation of microorganisms
compares favourably with the routine methods currently
used in clinical microbiology laboratories.
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